2025-03-282026-03-312026-03-31false16350580THE CHARTHAM SKIN & MEDICAL AESTHETICS CLINIC LTD2026-09-22falseiso4217:GBPxbrli:pure163505802025-03-27163505802026-03-31163505802025-03-282026-03-31163505802025-03-26163505802025-03-27163505802025-03-272025-03-2716350580bus:SmallEntities2025-03-282026-03-3116350580bus:AuditExempt-NoAccountantsReport2025-03-282026-03-3116350580bus:FullAccounts2025-03-282026-03-3116350580bus:PrivateLimitedCompanyLtd2025-03-282026-03-3116350580core:WithinOneYear2026-03-3116350580core:AfterOneYear2026-03-3116350580core:WithinOneYear2025-03-2716350580core:AfterOneYear2025-03-2716350580core:ShareCapital2026-03-3116350580core:SharePremium2026-03-3116350580core:RevaluationReserve2026-03-3116350580core:OtherReservesSubtotal2026-03-3116350580core:RetainedEarningsAccumulatedLosses2026-03-3116350580core:ShareCapital2025-03-2716350580core:SharePremium2025-03-2716350580core:RevaluationReserve2025-03-2716350580core:OtherReservesSubtotal2025-03-2716350580core:RetainedEarningsAccumulatedLosses2025-03-2716350580core:LandBuildings2026-03-3116350580core:PlantMachinery2026-03-3116350580core:Vehicles2026-03-3116350580core:FurnitureFittings2026-03-3116350580core:OfficeEquipment2026-03-3116350580core:NetGoodwill2026-03-3116350580core:IntangibleAssetsOtherThanGoodwill2026-03-3116350580core:ListedExchangeTraded2026-03-3116350580core:UnlistedNon-exchangeTraded2026-03-3116350580core:LandBuildings2025-03-2716350580core:PlantMachinery2025-03-2716350580core:Vehicles2025-03-2716350580core:FurnitureFittings2025-03-2716350580core:OfficeEquipment2025-03-2716350580core:NetGoodwill2025-03-2716350580core:IntangibleAssetsOtherThanGoodwill2025-03-2716350580core:ListedExchangeTraded2025-03-2716350580core:UnlistedNon-exchangeTraded2025-03-2716350580core:LandBuildings2025-03-282026-03-3116350580core:PlantMachinery2025-03-282026-03-3116350580core:Vehicles2025-03-282026-03-3116350580core:FurnitureFittings2025-03-282026-03-3116350580core:OfficeEquipment2025-03-282026-03-3116350580core:NetGoodwill2025-03-282026-03-3116350580core:IntangibleAssetsOtherThanGoodwill2025-03-282026-03-3116350580core:ListedExchangeTraded2025-03-282026-03-3116350580core:UnlistedNon-exchangeTraded2025-03-282026-03-3116350580core:MoreThanFiveYears2025-03-282026-03-3116350580core:Non-currentFinancialInstruments2026-03-3116350580core:Non-currentFinancialInstruments2025-03-2716350580dpl:CostSales2025-03-282026-03-3116350580dpl:DistributionCosts2025-03-282026-03-3116350580core:LandBuildings2025-03-282026-03-3116350580core:PlantMachinery2025-03-282026-03-3116350580core:Vehicles2025-03-282026-03-3116350580core:FurnitureFittings2025-03-282026-03-3116350580core:OfficeEquipment2025-03-282026-03-3116350580dpl:AdministrativeExpenses2025-03-282026-03-3116350580core:NetGoodwill2025-03-282026-03-3116350580core:IntangibleAssetsOtherThanGoodwill2025-03-282026-03-3116350580dpl:GroupUndertakings2025-03-282026-03-3116350580dpl:ParticipatingInterests2025-03-282026-03-3116350580dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-282026-03-3116350580core:ListedExchangeTraded2025-03-282026-03-3116350580dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-282026-03-3116350580core:UnlistedNon-exchangeTraded2025-03-282026-03-3116350580dpl:CostSales2025-03-272025-03-2716350580dpl:DistributionCosts2025-03-272025-03-2716350580core:LandBuildings2025-03-272025-03-2716350580core:PlantMachinery2025-03-272025-03-2716350580core:Vehicles2025-03-272025-03-2716350580core:FurnitureFittings2025-03-272025-03-2716350580core:OfficeEquipment2025-03-272025-03-2716350580dpl:AdministrativeExpenses2025-03-272025-03-2716350580core:NetGoodwill2025-03-272025-03-2716350580core:IntangibleAssetsOtherThanGoodwill2025-03-272025-03-2716350580dpl:GroupUndertakings2025-03-272025-03-2716350580dpl:ParticipatingInterests2025-03-272025-03-2716350580dpl:GroupUndertakingscore:ListedExchangeTraded2025-03-272025-03-2716350580core:ListedExchangeTraded2025-03-272025-03-2716350580dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-03-272025-03-2716350580core:UnlistedNon-exchangeTraded2025-03-272025-03-2716350580core:NetGoodwill2026-03-3116350580core:IntangibleAssetsOtherThanGoodwill2026-03-3116350580core:LandBuildings2026-03-3116350580core:PlantMachinery2026-03-3116350580core:Vehicles2026-03-3116350580core:FurnitureFittings2026-03-3116350580core:OfficeEquipment2026-03-3116350580core:AfterOneYear2026-03-3116350580core:WithinOneYear2026-03-3116350580core:ListedExchangeTraded2026-03-3116350580core:UnlistedNon-exchangeTraded2026-03-3116350580core:ShareCapital2026-03-3116350580core:SharePremium2026-03-3116350580core:RevaluationReserve2026-03-3116350580core:OtherReservesSubtotal2026-03-3116350580core:RetainedEarningsAccumulatedLosses2026-03-3116350580core:NetGoodwill2025-03-2716350580core:IntangibleAssetsOtherThanGoodwill2025-03-2716350580core:LandBuildings2025-03-2716350580core:PlantMachinery2025-03-2716350580core:Vehicles2025-03-2716350580core:FurnitureFittings2025-03-2716350580core:OfficeEquipment2025-03-2716350580core:AfterOneYear2025-03-2716350580core:WithinOneYear2025-03-2716350580core:ListedExchangeTraded2025-03-2716350580core:UnlistedNon-exchangeTraded2025-03-2716350580core:ShareCapital2025-03-2716350580core:SharePremium2025-03-2716350580core:RevaluationReserve2025-03-2716350580core:OtherReservesSubtotal2025-03-2716350580core:RetainedEarningsAccumulatedLosses2025-03-2716350580core:NetGoodwill2025-03-2616350580core:IntangibleAssetsOtherThanGoodwill2025-03-2616350580core:LandBuildings2025-03-2616350580core:PlantMachinery2025-03-2616350580core:Vehicles2025-03-2616350580core:FurnitureFittings2025-03-2616350580core:OfficeEquipment2025-03-2616350580core:AfterOneYear2025-03-2616350580core:WithinOneYear2025-03-2616350580core:ListedExchangeTraded2025-03-2616350580core:UnlistedNon-exchangeTraded2025-03-2616350580core:ShareCapital2025-03-2616350580core:SharePremium2025-03-2616350580core:RevaluationReserve2025-03-2616350580core:OtherReservesSubtotal2025-03-2616350580core:RetainedEarningsAccumulatedLosses2025-03-2616350580core:AfterOneYear2025-03-282026-03-3116350580core:WithinOneYear2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:CostValuation2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-282026-03-3116350580core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3116350580core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3116350580core:Non-currentFinancialInstrumentscore:CostValuation2025-03-2716350580core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-2716350580core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-2716350580bus:Director12025-03-282026-03-3116350580core:FurnitureFittingsToolsEquipment2025-03-282026-03-3116350580core:FurnitureFittingsToolsEquipment2026-03-3116350580core:FurnitureFittingsToolsEquipment2025-03-27

THE CHARTHAM SKIN & MEDICAL AESTHETICS CLINIC LTD

Registered Number
16350580
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2026

THE CHARTHAM SKIN & MEDICAL AESTHETICS CLINIC LTD
Company Information
for the period from 28 March 2025 to 31 March 2026

Director

K. Booth

Registered Address

The Old Bakery Rattington Street
Chartham
Canterbury
CT4 7JG

Registered Number

16350580 (England and Wales)
THE CHARTHAM SKIN & MEDICAL AESTHETICS CLINIC LTD
Balance Sheet as at
31 March 2026

Notes

2026

£

£

Fixed assets
Tangible assets32,663
2,663
Current assets
Debtors412,629
Cash at bank and on hand969
13,598
Creditors amounts falling due within one year5(6,440)
Net current assets (liabilities)7,158
Total assets less current liabilities9,821
Creditors amounts falling due after one year6(8,911)
Provisions for liabilities7(506)
Net assets404
Capital and reserves
Called up share capital100
Profit and loss account304
Shareholders' funds404
The financial statements were approved and authorised for issue by the Director on 22 September 2026, and are signed on its behalf by:
K. Booth
Director
Registered Company No. 16350580
THE CHARTHAM SKIN & MEDICAL AESTHETICS CLINIC LTD
Notes to the Financial Statements
for the period ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery5
Fixtures and fittings4
Office Equipment3
2.Average number of employees

2026
Average number of employees during the year0
3.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
Additions1,3331,6162313,180
At 31 March 261,3331,6162313,180
Depreciation and impairment
Charge for year11135353517
At 31 March 2611135353517
Net book value
At 31 March 261,2221,2631782,663
At 27 March 25----
4.Debtors: amounts due within one year

2026

£
Other debtors12,629
Total12,629
5.Creditors: amounts due within one year

2026

£
Taxation and social security4,543
Other creditors866
Accrued liabilities and deferred income1,031
Total6,440
6.Creditors: amounts due after one year

2026

£
Other creditors8,911
Total8,911
7.Provisions for liabilities

2026

£
Net deferred tax liability (asset)506
Total506